Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mayeux

Showing results (211-220 of 325) with videos related to

Pageof 33
Sort By:
Neurology|September 26, 1997
Altered systemic iron metabolism in Parkinson's diseaseG Logroscino, K Marder, J Graziano, et al.
Archives of Neurology|May 18, 2000
No association between a presenilin 1 polymorphism and Alzheimer diseaseS N Romas, R Mayeux, M X Tang, et al.
Archives of Neurology|October 1, 1991
Tritiated imipramine binding. A peripheral marker for serotonin in Parkinson's diseaseM Sano, M Stanley, A Lawton, et al.
International Journal of Geriatric Psychiatry|July 9, 1999
Rates of dementia in three ethnoracial groupsB J Gurland, D E Wilder, R Lantigua, et al.
Neurology|July 1, 1996
Risk of Parkinson's disease among first-degree relatives: A community-based studyK Marder, M X Tang, H Mejia, et al.
Neurology|November 12, 2003
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and riskR Mayeux, L S Honig, M-X Tang, et al.
Journal of the American Geriatrics Society|October 19, 2000
The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological studyF Massoud, G Devi, J T Moroney, et al.
Lancet (London, England)|August 17, 1996
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's diseaseM X Tang, D Jacobs, Y Stern, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenesM Hirano, A Shtilbans, R Mayeux, et al.
Acta Neuropathologica|January 1, 1987
Diffuse Lewy body disease. Neuropathological and biochemical studies of six patientsD W Dickson, P Davies, R Mayeux, et al.
Pageof 33

Showing results (211-220 of 325) with videos related to

Sort By:
Pageof 33
Neurology|September 26, 1997
Altered systemic iron metabolism in Parkinson's diseaseG Logroscino, K Marder, J Graziano, et al.
Archives of Neurology|May 18, 2000
No association between a presenilin 1 polymorphism and Alzheimer diseaseS N Romas, R Mayeux, M X Tang, et al.
Archives of Neurology|October 1, 1991
Tritiated imipramine binding. A peripheral marker for serotonin in Parkinson's diseaseM Sano, M Stanley, A Lawton, et al.
International Journal of Geriatric Psychiatry|July 9, 1999
Rates of dementia in three ethnoracial groupsB J Gurland, D E Wilder, R Lantigua, et al.
Neurology|July 1, 1996
Risk of Parkinson's disease among first-degree relatives: A community-based studyK Marder, M X Tang, H Mejia, et al.
Neurology|November 12, 2003
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and riskR Mayeux, L S Honig, M-X Tang, et al.
Journal of the American Geriatrics Society|October 19, 2000
The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological studyF Massoud, G Devi, J T Moroney, et al.
Lancet (London, England)|August 17, 1996
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's diseaseM X Tang, D Jacobs, Y Stern, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenesM Hirano, A Shtilbans, R Mayeux, et al.
Acta Neuropathologica|January 1, 1987
Diffuse Lewy body disease. Neuropathological and biochemical studies of six patientsD W Dickson, P Davies, R Mayeux, et al.
Pageof 33